Announcements Trials

Browse Landscape

Phase

Status

Completed 12 Terminated 4 Withdrawn 3 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Gynecologic 1 CNS 1 Breast 1

Conditions

Neoplasms, Plasma Cell 1 Multiple Myeloma 1

Interventions

Dexamethasone 70 Cyclophosphamide 44 Bortezomib 41 Lenalidomide 25 Melphalan 24 Thalidomide 19 pomalidomide 17 daratumumab 14 fludarabine 13 carfilzomib 10 Filgrastim 8 Doxorubicin 8 Busulfan 6 isatuximab 5 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Calcium Dobesilate 5 Bendamustine Hydrochloride 5 selinexor 4 sargramostim 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Etoposide 4 Clarithromycin 4 liposomal doxorubicin 3 ixazomib 3 dexamethasone acetate 3 Radiotherapy 3 Neoadjuvant Therapy 3 Mycophenolic Acid 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Vorinostat × Plasma cell × Clear all

NCT01554852 2018-06-11

Myeloma XI

University of Leeds

Phase 3 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡